Holdings
Gilead Sciences, Inc.
As of Sep 30, 2026, Gilead Sciences, Inc. reported 4 positions worth US$1.46B. Largest: Arcus Biosciences, Inc., Lakefront Biotherapeutics and Assembly Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Arcus Biosciences, Inc. | 31.4M | US$812M | no change | Sep 30, 2026 |
| Lakefront Biotherapeutics | 16.7M | US$501M | no change | Sep 30, 2026 |
| Assembly Biosciences, Inc. | 4.98M | US$117M | no change | Sep 30, 2026 |
| Kyverna Therapeutics, Inc. | 4.13M | US$28.1M | no change | Sep 30, 2026 |